a therapeutically focused leader in research-based drug development, medpace builds strong strategic partnerships with select sponsors to advance the most efficient and cost-effective path to drug approval. as a full service, global clinical research organ

Medpace Holdings, Inc. Common Stock

Bought 3% more MEDP

This member connected a brokerage account and is sharing trades and portfolio performance with the community. 

Public Portfolio

Irritable Investor

Bought 7% more MEDP

Bought 5% more MEDP

John

Bought 17% more MEDP

Brett

Bought <1% more MEDP

New position in MEDP

Sold 50% of MEDP

Camden Jones

Bought 14% more MEDP

Sold 33% of MEDP

Bought 2% more MEDP

Bought 4% more MEDP

Bought 48% more MEDP

Bought 104% more MEDP

This member is verified by the Commonstock team based on their contributions to the Commonstock community. 

Verified Member

Josh Kohn-Lindquist

Bought 237% more MEDP

Bought 15% more MEDP